CNE100002GC4
CNE100002GC4
AUTOBIO DIAGNOSTICS CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 19.11B EUR | 16.58B EUR | 19.11B EUR |
Enterprise Value | 16.06B EUR | 15.39B EUR | 18.38B EUR |
Valuation Multiples | |||
Trailing P/E | 19.45x | 16.47x | 18.81x |
Forward P/E | 12.03x | -- | -- |
Price to Sales | 4.53x | 3.93x | 4.6x |
Price to Book | 2.2x | 1.91x | 2.09x |
EV/Revenue | 3.8x | 3.64x | 4.43x |
EV/EBITDA | 10.96x | 12.9x | 15.29x |
Price to FCF (P/FCF) | 34.45x | 40.44x | 42.1x |
EV/FCF | 28.94x | 37.52x | 40.49x |
FCF Yield | 2.9% | 2.47% | 2.38% |